122 related articles for article (PubMed ID: 9630605)
1. Antimutagenic structural modification of quinoline assessed by an in vivo mutagenesis assay using lacZ-transgenic mice.
Miyata Y; Saeki K; Kawazoe Y; Hayashi M; Sofuni T; Suzuki T
Mutat Res; 1998 May; 414(1-3):165-9. PubMed ID: 9630605
[TBL] [Abstract][Full Text] [Related]
2. [Anti-carcinogenic structural modification by fluorine-substitution in aza-polycyclic aromatic hydrocarbons].
Saeki K
Yakugaku Zasshi; 2000 Dec; 120(12):1373-85. PubMed ID: 11193386
[TBL] [Abstract][Full Text] [Related]
3. In vivo mutagenesis by the hepatocarcinogen quinoline in the lacZ transgenic mouse: evidence for its in vivo genotoxicity.
Suzuki T; Miyata Y; Saeki K; Kawazoe Y; Hayashi M; Sofuni T
Mutat Res; 1998 Jan; 412(2):161-6. PubMed ID: 9539970
[TBL] [Abstract][Full Text] [Related]
4. Modification of the carcinogenic potency of quinoline, a hepatocarcinogen, by fluorine atom substitution: evaluation of carcinogenicity by a medium-term assay.
Saeki K; Kadoi M; Kawazoe Y; Futakuchi M; Tiwawech D; Shirai T
Biol Pharm Bull; 1997 Jan; 20(1):40-3. PubMed ID: 9013804
[TBL] [Abstract][Full Text] [Related]
5. In vivo mutagenicity of benzo[f]quinoline, benzo[h]quinoline, and 1,7-phenanthroline using the lacZ transgenic mice.
Yamada K; Suzuki T; Kohara A; Hayashi M; Mizutani T; Saeki K
Mutat Res; 2004 Apr; 559(1-2):83-95. PubMed ID: 15066577
[TBL] [Abstract][Full Text] [Related]
6. Hepatocarcinogen quinoline induces G:C to C:G transversions in the cII gene in the liver of lambda/lacZ transgenic mice (MutaMouse).
Suzuki T; Wang X; Miyata Y; Saeki K; Kohara A; Kawazoe Y; Hayashi M; Sofuni T
Mutat Res; 2000 Nov; 456(1-2):73-81. PubMed ID: 11087898
[TBL] [Abstract][Full Text] [Related]
7. Nitrogen-substitution effect on in vivo mutagenicity of chrysene.
Yamada K; Suzuki T; Kohara A; Kato TA; Hayashi M; Mizutani T; Saeki K
Mutat Res; 2005 Sep; 586(1):1-17. PubMed ID: 16054434
[TBL] [Abstract][Full Text] [Related]
8. Effects of oligofluorine substitution on the mutagenicity of quinoline: a study with twelve fluoroquinoline derivatives.
Kato T; Saeki K; Kawazoe Y; Hakura A
Mutat Res; 1999 Feb; 439(2):149-57. PubMed ID: 10023045
[TBL] [Abstract][Full Text] [Related]
9. Bioassay of quinoline, 5-fluoroquinoline, carbazole, 9-methylcarbazole and 9-ethylcarbazole in newborn mice.
Weyand EH; Defauw J; McQueen CA; Meschter CL; Meegalla SK; LaVoie EJ
Food Chem Toxicol; 1993 Oct; 31(10):707-15. PubMed ID: 8225128
[TBL] [Abstract][Full Text] [Related]
10. Anti-mutagenic structural modification by fluorine-substitution in highly mutagenic 4-methylquinoline derivatives.
Kato T; Hakura A; Mizutani T; Saeki K
Mutat Res; 2000 Feb; 465(1-2):173-82. PubMed ID: 10708984
[TBL] [Abstract][Full Text] [Related]
11. In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta mice and c-myc/lacZ double transgenic mice.
Davis CD; Dacquel EJ; Schut HA; Thorgeirsson SS; Snyderwine EG
Mutat Res; 1996 Sep; 356(2):287-96. PubMed ID: 8841498
[TBL] [Abstract][Full Text] [Related]
12. Procarbazine genotoxicity in the MutaMouse; strong clastogenicity and organ-specific induction of lacZ mutations.
Suzuki T; Uno Y; Idehara K; Baba T; Maniwa J; Ohkouchi A; Wang X; Hayashi M; Sofuni T; Tsuruoka M; Miyajima H; Kondo K
Mutat Res; 1999 Aug; 444(2):269-81. PubMed ID: 10521668
[TBL] [Abstract][Full Text] [Related]
13. N-Nitrosodi-n-propylamine induces organ specific mutagenesis with specific expression times in lacZ transgenic mice.
Itoh S; Miura M; Itoh T; Miyauchi Y; Suga M; Takahashi Y; Kasahara Y; Yamamura E; Hirono H; Shimada H
Mutat Res; 1999 Aug; 444(2):309-19. PubMed ID: 10521671
[TBL] [Abstract][Full Text] [Related]
14. Clastogenicity of quinoline derivatives tested by micronucleus induction in vivo in the hepatocytes of partially hepatectomized mice.
Saeki K; Kadoi M; Kawazoe Y; Igarashi M; Shimada H
Biol Pharm Bull; 2000 Feb; 23(2):219-21. PubMed ID: 10706388
[TBL] [Abstract][Full Text] [Related]
15. Repeated-dose liver and gastrointestinal tract micronucleus assays for quinoline in rats.
Uno F; Tanaka J; Ueda M; Nagai M; Fukumuro M; Natsume M; Oba M; Akahori A; Masumori S; Takami S; Wako Y; Kawasako K; Kougo Y; Ohyama W; Narumi K; Fujiishi Y; Okada E; Hayashi M
Mutat Res Genet Toxicol Environ Mutagen; 2015 Mar; 780-781():51-5. PubMed ID: 25892622
[TBL] [Abstract][Full Text] [Related]
16. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
[TBL] [Abstract][Full Text] [Related]
17. Hepatocarcinogen 4-methylquinoline induced G:C to C:G transversions in the cII gene in the liver of lambda/lacZ transgenic mice (Muta™Mouse).
Kitamura Y; Suzuki T; Kohara A; Saeki KI
Mutat Res; 2020; 821():111709. PubMed ID: 32497932
[TBL] [Abstract][Full Text] [Related]
18. Regional mutagenicity of heterocyclic amines in the intestine: mutation analysis of the cII gene in lambda/lacZ transgenic mice.
Itoh T; Kuwahara T; Suzuki T; Hayashi M; Ohnishi Y
Mutat Res; 2003 Aug; 539(1-2):99-108. PubMed ID: 12948818
[TBL] [Abstract][Full Text] [Related]
19. The concomitant detection of gene mutation and micronucleus induction by mitomycin C in vivo using lacZ transgenic mice.
Suzuki T; Hayashi M; Sofuni T; Myhr BC
Mutat Res; 1993 Feb; 285(2):219-24. PubMed ID: 7678894
[TBL] [Abstract][Full Text] [Related]
20. Target organ and time-course in the mutagenicity of five carcinogens in MutaMouse: a summary report of the second collaborative study of the transgenic mouse mutation assay by JEMS/MMS.
Suzuki T; Itoh S; Nakajima M; Hachiya N; Hara T
Mutat Res; 1999 Aug; 444(2):259-68. PubMed ID: 10521667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
